News on issues related to managing clinical laboratories.
The company's patent related to labeled nucleotides for use as diagnostic tools and as therapeutic agents has been invalidated.
According to the company, it has shipped more than 1,700 of the IVD analyzer platforms since launching sales globally in 2017.
The center will initially use the system for prostate, and head and neck cancers and in the future will let LabCorp patients access Mount Sinai pathologists.
Nursing home lab testing, traditionally a low margin and labor intensive business, has been particularly impacted by PAMA-driven reimbursement cuts.
About 200,000 LabCorp patients may have had their credit card or bank information improperly accessed by the breach, which also hit 11.9 million Quest patients.
